MIRABELLA FINANCIAL SERVICES LLP
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1538853
London, X0
Position in ESPR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$118,439
+$118,439 QoQ
Shares Held
37,481
+98.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 40 holders
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MIRABELLA FINANCIAL SERVICES LLP holds $2,185,125 across 7 Drug Manufacturers - Specialty & Generic names. ESPR ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
5,693 | $631,581 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
20,625 | $357,018 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
8,296 | $300,315 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
8,057 | $279,336 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
5,302 | $250,625 | |
| 6 | PRGO |
PERRIGO Co plc
|
23,851 | $247,811 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
This page
|
37,481 | $118,439 |
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,439 | 37,481 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | — | 18,858 | Shares | Sole | 2026-05-12 | |
| 2023-12-31 | — | 42,200 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||